| Mapping the path to excellence: Evaluation of the diagnostic and treatment tools for invasive fungal infections in the balkans N Pantić, A Barać, V Mano, A Dedeić-Ljubović, I Malkodanski, O Jaksić, ... Journal of Infection and Public Health 17 (8), 102493, 2024 | | 2024 |
| Immunogenicity, reactogenicity and safety of a second booster with BNT162b2 or full-dose mRNA-1273: a randomised VACCELERATE trial in adults≥ 75 years (EU-COVAT-1-AGED Part B) J Stemler, L Yeghiazaryan, C Stephan, KGI Mohn, AJ Carcas-Sansuan, ... International Journal of Infectious Diseases, 107161, 2024 | | 2024 |
| Correction: Need for ICU and outcome of critically ill patients with COVID-19 and haematological malignancies: results from the EPICOVIDEHA survey T Lahmer, J Salmanton-García, F Marchesi, S El-Ashwah, M Nucci, ... Infection 52 (3), 1191-1194, 2024 | | 2024 |
| Insights into invasive fungal infection diagnostic and treatment capacities in tertiary care centres of Germany J Salmanton-García, M Simon, AH Groll, O Kurzai, T Lahmer, ... JAC-Antimicrobial Resistance 6 (3), dlae083, 2024 | | 2024 |
| Challenges in assessing the immunization status of adults in Germany—lessons from a population-based VACCELERATE survey on polio vaccination JA Nacov, J Stemler, J Salmanton-García, LM Cremer, M Zeitlinger, ... Infection, 1-12, 2024 | | 2024 |
| Decoding the historical tale: COVID-19 impact on haematological malignancy patients—EPICOVIDEHA insights from 2020 to 2022 J Salmanton-García, F Marchesi, F Farina, B Weinbergerová, F Itri, ... EClinicalMedicine 71, 2024 | 2 | 2024 |
| Costs and resource utilization patterns in surgical site infections: a pre-COVID-19 perspective from France, Germany, Spain, and the UK J Salmanton-García, C Bruns, J Rutz, M Albertsmeier, J Ankert, L Bernard, ... Journal of Hospital Infection 147, 123-132, 2024 | 1 | 2024 |
| Education pathways and key tasks for research nurses in Europe, results from a VACCELERATE online survey J Salmanton-García, FA Stewart, P Wipfler, SHI Hofstraat, ... Nurse Education in Practice 77, 103953, 2024 | 1 | 2024 |
| Perspectives of European Patient Advocacy Groups on Volunteer Registries and Vaccine Trials: VACCELERATE Survey Study S Themistocleous, CD Argyropoulos, P Vogazianos, G Shiamakkides, ... JMIR public health and surveillance 10, e47241, 2024 | | 2024 |
| Individual and institutional predisposing factors of MRSA surgical site infection and outcomes—a retrospective case-control-study in 14 European high-volume surgical centres J Rutz, JH Naendrup, C Bruns, AY Classen, J Salmanton-García, H Seifert, ... JAC-Antimicrobial Resistance 6 (2), dlae046, 2024 | | 2024 |
| The Cologne ECMM Excellence Center: A Two-Year Analysis of External Consultation Service for Invasive Fungal Infections J Salmanton-García, P Koehler, JH Grothe, SC Mellinghoff, E Sal, ... Mycopathologia 189 (2), 25, 2024 | 1 | 2024 |
| No Impact of Dietary Restrictions on the Risk for Infection in Pediatric Patients With Cancer: A Monocenter Analysis A Barnbrock, J Salmanton-García, F Lankes, K Bochennek, S Schöning, ... JCO Oncology Practice 20 (4), 503-508, 2024 | | 2024 |
| Necrotizing pancreatitis with invasive candidiasis and candidemia due to Candida albicans and pan-echinocandin-resistant Candida glabrata L Rahimli, J Salmanton-García, P Kasper, M Simon, OA Cornely, ... Medical Mycology Case Reports 43, 100636, 2024 | | 2024 |
| Need for ICU and outcome of critically ill patients with COVID-19 and haematological malignancies: results from the EPICOVIDEHA survey T Lahmer, J Salmanton-García, F Marchesi, S El-Ashwah, M Nucci, ... Infection, 1-17, 2024 | 1 | 2024 |
| Global guideline for the diagnosis and management of cryptococcosis: an initiative of the ECMM and ISHAM in cooperation with the ASM CC Chang, TS Harrison, TA Bicanic, M Chayakulkeeree, TC Sorrell, ... The Lancet Infectious Diseases, 2024 | 16 | 2024 |
| Multicentric study on the clinical mycology capacity and access to antifungal treatment in Portugal R Fernandes, R Sabino, C Cunha, OA Cornely, A Carvalho, ... Mycopathologia 189 (1), 15, 2024 | 2 | 2024 |
| Laboratory and clinical management capacity for invasive fungal infections: the Italian landscape A Vena, M Bassetti, L Mezzogori, F Marchesi, M Hoenigl, DR Giacobbe, ... Infection 52 (1), 197-208, 2024 | 5 | 2024 |
| The mortality of COVID-19 in CML patients from 2020 until 2022: results from the EPICOVIDEHA survey S El-Ashwah, J Salmanton-García, YM Bilgin, F Itri, P Žák, ... Leukemia & lymphoma 65 (2), 199-208, 2024 | 3 | 2024 |
| Survival in multiple myeloma and SARS‐COV‐2 infection through the COVID‐19 pandemic: Results from the EPICOVIDEHA registry P Musto, J Salmanton‐García, N Sgherza, R Bergantim, F Farina, ... Hematological Oncology 42 (1), 2024 | 3 | 2024 |
| Predicting the next pandemic: VACCELERATE ranking of the World Health Organization's Blueprint for Action to Prevent Epidemics J Salmanton-García, P Wipfler, J Leckler, P Nauclér, PW Mallon, ... Travel Medicine and Infectious Disease 57, 102676, 2024 | | 2024 |
Oliver CornelyUniversity of CologneVerified email at uk-koeln.de